Purchases and Sales Made in Q4 2021 in Zynerba Pharmaceuticals, Inc. (ZYNE)
This table provides information about the institutional ownership of Zynerba Pharmaceuticals, Inc. (ZYNE) during Q4 2021. The information is specifically focused on institutions that hold shares of Zynerba Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-67.8K- 38.68% |
$195K - $292K
|
108K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-164K- 86.3% |
$473K - $707K
|
26.1K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-249K- 17.68% |
$716K - $1.07M
|
1.16M
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-388KClosed |
$1.12M - $1.67M
|
0
$0
|